The neurobiology of schizophrenia

Robert A. Littrell, Mark Schneiderhan

Research output: Contribution to journalReview article

7 Scopus citations

Abstract

The hypothesis that altered dopamine function is a major factor in the etiology of schizophrenia has persisted for some time, and changes in other neurochemical systems are strongly implicated as well. These findings are supported by the recent development of new, effective antipsychotic agents, such as clozapine and risperidone, whose actions are attributed to their combined serotonin and dopamine antagonism. In addition to their clinical efficacy, these agents are associated with substantially fewer extrapyramidal adverse effects. Continued research to identify the neurochemical alterations of psychotic diseases will undoubtedly have a favorable impact on the development of improved therapeutic regimens.

Original languageEnglish (US)
Pages (from-to)143S-147S
JournalPharmacotherapy
Volume16
Issue number6 II
StatePublished - Nov 1 1996

Fingerprint Dive into the research topics of 'The neurobiology of schizophrenia'. Together they form a unique fingerprint.

  • Cite this

    Littrell, R. A., & Schneiderhan, M. (1996). The neurobiology of schizophrenia. Pharmacotherapy, 16(6 II), 143S-147S.